Blood Transfusion Rate in Patients Undergoing Benign Prostatic Hyperplasia

Background and Objective: Benign Prostatic Hyperplasia (BPH) is defined as the enlargement of prostate gland in presence urinary symptoms without any evidence malignancy. For patients who have failed medical treatment first line therapy, surgical intervention will be administered treatment. Hemorrhage one most dreadful serious complications surgery. Bleeding can often significant lead to increased morbidity occasionally mortality. If it persists, may necessitate blood transfusion clot retention postoperative period. Materials Methods: This study was conducted on 87 with benign prostatic hyperplasia, underwent (open prostatectomy transurethral resection prostate) for a year. The volume packed cell these determined compared based method other variables. collected data were analyzed SPSS (version 24). Results: mean age 71.3±9.56 years, 26.4% subjects under 65 years old. Among cases, 93.1% surgery 7.7% received transfusion. It found that 41.4%, 12.6%, 10.3%, 3.4%, 1.1% participants had high pressure, diabetes, ischemic heart disease, hypothyroidism, dyslipidemia, respectively. means pre- post-operative hemoglobin obtained at 13.16±1.83 12.33±2.17, respectively, those hematocrit estimated 38.64±4.84 36.72±5.72, Conclusion: Transurethral lower rate transfusion, open history underlying diseases not significantly related percentage patients. However, frequency higher hypertension than diseases; nevertheless, significant.